StemCell Therapy

This innovative data linking will enable us to better understand how common MSK conditions are, how they progress, what treatments are best and who needs which services and when.

It is one of two projects awarded funding in partnership with the charity Versus Arthritis, who have contributed 250,000 towards the grants.

It will link existing, and new, data in novel ways, to address key research questions and inform policy and practice:

Tim Gardam, Chief Executive of the Nuffield Foundation said: The Nuffield Foundation is committed to improving peoples lives through better understanding of the issues affecting their life chances. Together these new projects will improve our understanding of the impact of MSK conditions on both individuals and wider society. We are delighted to be partnering with Versus Arthritis to help improve the health and well-being of people living with MSK conditions by influencing future practice, policy and research.

Amanda Neylon Director of Insight Data and Technology at Versus Arthritis said: This is exceptional research that will greatly improve our understanding of the effects of arthritis and improve the way people are treated. Meaningful data are key to providing high value musculoskeletal services as its essential for understanding the health needs of local populations, the activity performed by services and the outcomes they deliver.

Our partnership with the Nuffield Foundation is an excellent example of how working with others can maximise the impact of research funding and allow us to achieve more than we could do on our own.

Read the rest here:
1.5 million for research to improve the lives of people living with musculoskeletal conditions - The University of Manchester

This entry was posted on April 12, 2020 at 11:51 pm and is filed under Arthritis. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |